| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Intervention Services Inc is a Maitland, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hemostasis Corp is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Harborview Health Care is a Morehead City, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EBD Group is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.